📰 Dermtech Daily News
Dermtech Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dermtech Daily. Real-time updates on events, politics, business and more.
June 3, 2024
DermTech, Inc. (NASDAQ:DMTK – Get Free Report) saw a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,850,000 shares, a drop of 7.8% from the April 30th total of 3,090,000 shares. Based on an average daily volume of 599,200 shares, the short-interest ratio is […]
April 21, 2024
DermTech (NASDAQ:DMTK – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Lake Street Capital in a research report issued on Friday, Benzinga reports. They currently have a $0.63 price target on the stock. Lake Street Capital’s target price suggests a potential downside of 2.17% from the stock’s previous close. A […]
April 21, 2024
DermTech (NASDAQ:DMTK – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by equities researchers at Stephens in a research note issued on Friday, Benzinga reports. They presently have a $1.50 price objective on the stock. Stephens’ price target points to a potential upside of 132.92% from the company’s previous close. Separately, BTIG Research […]
April 19, 2024
DermTech, Inc. (NASDAQ:DMTK – Get Free Report) fell 0.9% on Tuesday . The company traded as low as $0.60 and last traded at $0.61. 48,834 shares were traded during mid-day trading, a decline of 85% from the average session volume of 321,284 shares. The stock had previously closed at $0.62. Analyst Upgrades and Downgrades Separately, […]
February 28, 2024
DermTech (NASDAQ:DMTK – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Thursday, February 29th. Analysts expect DermTech to post earnings of ($0.54) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link. DermTech Stock […]
November 4, 2023
DermTech (NASDAQ:DMTK – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk. Profitability This table compares DermTech and BioNexus […]
November 1, 2023
DermTech, Inc. (NASDAQ:DMTK – Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totalling 5,230,000 shares, a growth of 7.2% from the September 30th total of 4,880,000 shares. Based on an average daily trading volume, of 249,400 shares, the short-interest ratio […]
July 29, 2023
DermTech (NASDAQ:DMTK – Get Free Report) and Syneos Health (NASDAQ:SYNH – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends. Volatility & Risk DermTech has a beta of 2.14, […]
July 27, 2023
DermTech (NASDAQ:DMTK – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, August 3rd. Analysts expect DermTech to post earnings of ($0.95) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. DermTech (NASDAQ:DMTK – Get […]
July 21, 2023
DermTech, Inc. (NASDAQ:DMTK – Get Free Report) saw a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 3,640,000 shares, a growth of 12.7% from the June 15th total of 3,230,000 shares. Based on an average daily volume of 417,500 shares, the short-interest ratio is […]